Our Drug Discovery & Development Approach

For over 20 years, our biologists and chemists have worked side-by-side to push the boundaries of drug discovery and development, driven by a shared purpose: advancing science and innovation to improve patients' lives.

Today, our portfolio is focused across three franchises: Hematology, Oncology and Inflammation and Autoimmunity (IAI), including Dermatology. By concentrating our efforts, we are driving meaningful progress and impact for patients.

We integrate advanced technologies, including artificial intelligence, into our discovery and development approach. By combining our scientific expertise, rich proprietary data and advanced technologies to improve how we discover targets, design experiments and make development decisions, we can interpret complex data more efficiently and advance the most promising programs.

The treatments we can deliver for patients tomorrow will be defined by how we accelerate. Because we don't wait for the future—we build it together.